IP Library › Granted Patent US 11,439,681
Granted Patent B2
US 11,439,681 · App. 17/120,207 · Granted Sep 13, 2022

Traditional Chinese medicine composition for treating type 2 diabetes

Inventor: Jinchang Ai (Yueyang, CN)
A61K36/73A61K36/11A61K36/185A61K36/258A61K36/288A61K36/53A61K36/605A61K36/82A61K36/899
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,439,681
App. No.
17/120,207
Granted
Sep 13, 2022
Kind
B2
Abstract

The application discloses a traditional Chinese medicine composition for treating of type 2 diabetes, comprising the following raw materials: wild Descolor Cinquefoil Herb, wild Rhizoma imperatae, wild Root and Rhizome of Japanese Climbing Fern, Ginseng leaf (over 7 years), wild Rough Melic, wild Vitex negundo L., Morus alba L., green tea, wild auricularia, corn silk, dandelion root. The traditional Chinese medicine composition of the application is suitable for patients with type 2 diabetes and complications of type 2 diabetes, which has no adverse reactions and stable curative effect.

Claims (20)

1. A pharmaceutical composition for treating type 2 diabetes, comprising therapeutically effective amounts of the following raw materials: wild Descolor Cinquefoil Herb, wild Rhizoma imperatae, wild Root and Rhizome of Japanese Climbing Fern, Ginseng leaf of over 7 years, wild Rough Melic, wild Vitex negundo L., Morus alba L., green tea, wild Auricularia, corn silk, and dandelion root.

2. The pharmaceutical composition for treating type 2 diabetes according to claim 1 , comprising the following weight ratio of said raw materials: 15-25 g wild Descolor Cinquefoil Herb, 15-25 g wild Rhizoma imperatae, 15-25 g wild Root and Rhizome of Japanese Climbing Fern, 10-20 g Ginseng leaf, 10-20 g wild Rough Melic, 10-20 g wild Vitex negundo L., 10-20 g Morus alba L., 10-20 g green tea, 10-20 g wild Auricularia, 10-20 g corn silk, and 10-20 g dandelion root.

3. The pharmaceutical composition for treating type 2 diabetes according to claim 2 , comprising the following weight ratio of said raw materials: 15 g wild Descolor Cinquefoil Herb, 15 g wild Rhizoma imperatae, 15 g wild Root and Rhizome of Japanese Climbing Fern, 10 g Ginseng leaf, 10 g wild Rough Melic, 10 g wild Vitex negundo L., 10 g Morus alba L., 10 g green tea, 10 g wild Auricularia, 10 g corn silk, and 10 g dandelion root.

4. The pharmaceutical composition for treating type 2 diabetes according to claim 2 , comprising the following weight ratio of said raw materials: 25 g wild Descolor Cinquefoil Herb, 25 g wild Rhizoma imperatae, 25 g wild Root and Rhizome of Japanese Climbing Fern, 20 g Ginseng leaf, 20 g wild Rough Melic, 20 g wild Vitex negundo L., 20 g Morus alba L., 20 g green tea, 20 g wild Auricularia, 20 g corn silk, and 20 g dandelion root.

5. The pharmaceutical composition for treating type 2 diabetes according to claim 2 , comprising the following weight ratio of said raw materials: 20 g wild Descolor Cinquefoil Herb, 20 g wild Rhizoma imperatae, 20 g wild Root and Rhizome of Japanese Climbing Fern, 15 g Ginseng leaf, 15 g wild Rough Melic, 15 g wild Vitex negundo L., 15 g Morus alba L., 15 g green tea, 15 g wild Auricularia, 15 g corn silk, and 15 g dandelion root.

6. The pharmaceutical composition for treating type 2 diabetes according to claim 1 , wherein traditional Chinese medicine composition is in the form of a decoction, powder, pill, or capsule.

7. The pharmaceutical composition for treating type 2 diabetes according to claim 6 , comprising the following weight ratio of said raw materials: 15-25 g wild Descolor Cinquefoil Herb, 15-25 g wild Rhizoma imperatae, 15-25 g wild Root and Rhizome of Japanese Climbing Fern, 10-20 g Ginseng leaf, 10-20 g wild Rough Melic, 10-20 g wild Vitex negundo L., 10-20 g Morus alba L., 10-20 g green tea, 10-20 g wild Auricularia, 10-20 g corn silk, and 10-20 g dandelion root.

8. The pharmaceutical composition for treating type 2 diabetes according to claim 6 , comprising the following weight ratio of raw materials: 15 g wild Descolor Cinquefoil Herb, 15 g wild Rhizoma imperatae, 15 g wild Root and Rhizome of Japanese Climbing Fern, 10 g Ginseng leaf, 10 g wild Rough Melic, 10 g wild Vitex negundo L., 10 g Morus alba L., 10 g green tea, 10 g wild Auricularia, 10 g corn silk, and 10 g dandelion root.

9. The pharmaceutical composition for treating type 2 diabetes according to claim 6 , comprising the following weight ratio of raw materials: 25 g wild Descolor Cinquefoil Herb, 25 g wild Rhizoma imperatae, 25 g wild Root and Rhizome of Japanese Climbing Fern, 20 g Ginseng leaf, 20 g wild Rough Melic, 20 g wild Vitex negundo L., 20 g Morus alba L., 20 g green tea, 20 g wild Auricularia, 20 g corn silk, and 20 g dandelion root.

10. The pharmaceutical composition for treating type 2 diabetes according to claim 6 , comprising the following weight ratio of raw materials: 20 g wild Descolor Cinquefoil Herb, 20 g wild Rhizoma imperatae, 20 g wild Root and Rhizome of Japanese Climbing Fern, 15 g Ginseng leaf, 15 g wild Rough Melic, 15 g wild Vitex negundo L., 15 g Morus alba L., 15 g green tea, 15 g wild Auricularia, 15 g corn silk, and 15 g dandelion root.

11. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 1 to said subject in need of such treatment.

12. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 2 to said subject in need of such treatment.

13. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 3 to said subject in need of such treatment.

14. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 4 to said subject in need of such treatment.

15. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 5 to said subject in need of such treatment.

16. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 6 to said subject in need of such treatment.

17. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 7 to said subject in need of such treatment.

18. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 8 to said subject in need of such treatment.

19. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 9 to said subject in need of such treatment.

20. A method for treating type 2 diabetes in a subject, comprising administering the composition of claim 10 to said subject in need of such treatment.

Priority Claims (1)
CN 202010339223.6 · Apr 26, 2020 · national
Continuity (1)
Related Publication 20210330730A1 · Oct 28, 2021
Cited By (1)
US 12,706,277